|Videos|June 23, 2021
Second Opinion: Double or Triple - Melanoma Ministration
2 experts join Deep Dive to discuss therapy selection for a specific set of melanoma, specifically focusing on doublet vs triplet therapy for BRAF mutant metastatic melanoma.
Related Articles
Deep Dive: Into Improving Patient Outcomes Through AIAugust 16th 2023
Behind the Science: Behind Chemotherapy ShortagesAugust 15th 2023
Deep Dive: Into Types of ChromatographyAugust 15th 2023
Deep Dive: Into Clinical Trials & Reproductive HealthAugust 4th 2023
Deep Dive: Into Diabetic RetinopathyAugust 3rd 2023
Deep Dive: Into AHN’s Fertility ClinicAugust 2nd 2023
